Loading
Latest filing published 11 Jun 2022 for Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.).
No signal scores available.
This profile gathers the share dealings of ThreeD Capital Inc. in Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.). We count 2 filings; the first trade dates from 8 June 2022 and the latest from 9 June 2022.
Every open-market trade on record is a purchase: 1 purchase worth €11k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
Most recently, on 11 June 2022, the filings show a transaction in Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.). The clock since the last published purchase (11 June 2022) now reads 1,597 days. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations